Showing 821 - 840 results of 1,890 for search '"Type 2 diabetes"', query time: 0.11s Refine Results
  1. 821

    Elevated fasting serum xylitol levels are associated with a lower risk of incident type 2 diabetes among individuals with prediabetes in the Chinese population by Yicheng Qi, Xiaoyong Li, Yu Liu, Meng Wang, Yiming Wu, Qing Su, Li Qin, Jing Ma

    Published 2025-02-01
    “…Although polyols affect glycometabolism, little is known about the association between fasting serum polyol levels of participants with habitual diet and the risk of prediabetes progressing to type 2 diabetes. Methods In this nested case-control study, 180 participants who developed from prediabetes to type 2 diabetes (progressors), and 180 matched controls (non-progressors) with prediabetes during a 3.5-year follow-up were enrolled. …”
    Get full text
    Article
  2. 822

    Measuring the Prevalence of Chronic Kidney Disease among Type 2 Diabetes Mellitus Patient in Hospital Jitra: A Population-Based Cohort Study by Norazila Abdul Ghani, Sharifah Nor Faiza Syed Hassan, Rusyidah Zainol Abidin, Zarmisha Zakaria, Fatin Farhana Ahmad Nasir, Ahmad Zulfitri Azmi

    Published 2025-01-01
    “…It is important to obtain accurate local data on CKD among patient with Type 2 Diabetes Mellitus (T2DM) patients to facilitate health-care planning including the review of health-care priorities, program activities, and allocation of resources. …”
    Get full text
    Article
  3. 823

    Plasma C1q/TNF-Related Protein-9 Levels Are Associated with Atherosclerosis in Patients with Type 2 Diabetes without Renal Dysfunction by Mariko Asada, Tomoaki Morioka, Yuko Yamazaki, Yoshinori Kakutani, Reina Kawarabayashi, Koka Motoyama, Katsuhito Mori, Shinya Fukumoto, Atsushi Shioi, Tetsuo Shoji, Masanori Emoto, Masaaki Inaba

    Published 2016-01-01
    “…We investigated the association between plasma CTRP9 levels and atherosclerosis in patients with type 2 diabetes. Methods. We included 419 patients with type 2 diabetes, 161 of whom had chronic kidney disease (CKD). …”
    Get full text
    Article
  4. 824

    Functional Status of Pancreatic α and β Cells in Type 2 Diabetes Mellitus Patients with Different Plasma Triglyceride Levels: A Retrospective Analysis by Hang Guo, Chunlei Ma, Xiaoming Wu, Congqing Pan

    Published 2021-01-01
    “…To investigate the functional status of pancreatic α and β cells in Type 2 diabetes mellitus (T2DM) patients with different plasma triglyceride (TG) levels. …”
    Get full text
    Article
  5. 825
  6. 826

    Patients’ and family members’ knowledge, attitudes and perceived family support for SMBG in type 2 diabetes: a fuzzy-set qualitative comparative analysis by Jun Lu, Xiaohong Li, Qian Zhao, Ying Guo, Xinying Yu, Yuheng Feng, Yuxi Zhao

    Published 2022-12-01
    “…Aims and objectives To examine the combined effects of the patient’s and family members’ knowledge, attitudes and perceived family support on self-monitoring of blood glucose (SMBG) behaviour of patients with type 2 diabetes.Design A cross-sectional design using the framework of knowledge–attitude–behaviour (KAB) combined with family support.Setting Shanghai, China.Participants Seventy type 2 diabetes patient–family member dyads recruited from 26 residential committees in Shanghai were investigated. …”
    Get full text
    Article
  7. 827

    Effectiveness of a personal health coaching intervention (diabetescoach) in patients with type 2 diabetes: protocol for an open-label, pragmatic randomised controlled trial by Oliver Faude, Fiona Streckmann, Lukas Zahner, Markus Gerber, Vivien Hohberg, Jan-Niklas Kreppke, Jan Kohl, Eleonora Seelig, Daniel König

    Published 2022-06-01
    “…Introduction The widespread prevalence of type 2 diabetes (T2D) not only influences patients’ daily lives but also has an economic impact on society. …”
    Get full text
    Article
  8. 828

    Identifying barriers that prevent US insured adults at-risk for and diagnosed with type 2 diabetes from accessing primary care services: An exploratory study by Tamara Crawford

    Published 2017-11-01
    “…Introduction: Type 2 diabetes is a condition that affects millions of individuals within the United States and it is one of the leading causes of death. …”
    Get full text
    Article
  9. 829

    Bioelectrical Impedance and Dual-Energy X-Ray Absorptiometry Assessments of Changes in Body Composition Following Exercise in Patients with Type 2 Diabetes Mellitus by Masae Miyatani, Pearl Yang, Scott Thomas, B. Catharine Craven, Paul Oh

    Published 2012-01-01
    “…We aimed to compare the level of agreement between leg-to-leg bioelectrical impedance analysis (LBIA) and dual-energy X-ray absorptiometry (DXA) for assessing changes in body composition following exercise intervention among individuals with Type 2 diabetes mellitus (T2DM). Forty-four adults with T2DM, age 53.2±9.1 years; BMI 30.8±5.9 kg/m2 participated in a 6-month exercise program with pre and post intervention assessments of body composition. …”
    Get full text
    Article
  10. 830
  11. 831

    Peripheral Arterial Disease and Its Associated Factors among Type 2 Diabetes Mellitus Patients at Debre Tabor General Hospital, Northwest Ethiopia by Yonas Akalu, Ambaye Birhan

    Published 2020-01-01
    “…However, there is no data on the prevalence of PAD among type 2 diabetes patients in Ethiopia. Therefore, the current study is aimed at determining the prevalence and associated factors of PAD among type 2 diabetes patients at Debre Tabor General Hospital, Debre Tabor, Northwest Ethiopia. …”
    Get full text
    Article
  12. 832

    Relationship between Serum 25-Hydroxyvitamin D and Lower Extremity Arterial Disease in Type 2 Diabetes Mellitus Patients and the Analysis of the Intervention of Vitamin D by Wan Zhou, Shan-Dong Ye

    Published 2015-01-01
    “…The aim of this study was to explore the relationship between serum 25-hydroxyvitamin D [25(OH)D] concentrations and lower extremity arterial disease (LEAD) in type 2 diabetes mellitus (T2DM) patients and to investigate the intervention effect of vitamin D. 145 subjects were assigned to a control group (Group NC), T2DM group (Group DM1), and T2DM complicated with LEAD group (Group DM2); then Group DM2 were randomly divided into Group DM3 who received oral hypoglycemic agents and Group DM4 who received oral hypoglycemic drugs and vitamin D3 therapy. …”
    Get full text
    Article
  13. 833

    Association between early‐stage diabetic nephropathy and the delayed monophasic glucose peak during oral glucose tolerance test in type 2 diabetes mellitus by Han Zhang, Hanqing Tang, Yunjuan Gu, Zhuqi Tang, Xiaoqin Zhao, Ranran Zhou, Ping Huang, Rongping Zhang, Xinlei Wang

    Published 2025-02-01
    “…ABSTRACT Aims To explore the relationships between the delayed monophasic glucose peak during oral glucose tolerance test (OGTT) and early‐stage diabetic nephropathy (DN) in patients with type 2 diabetes mellitus(T2DM), and to speculate its potential as a risk factor for early‐stage DN. …”
    Get full text
    Article
  14. 834

    High-Salt Intake Ameliorates Hyperglycemia and Insulin Resistance in WBN/Kob-Leprfa/fa Rats: A New Model of Type 2 Diabetes Mellitus by Yoshiichi Takagi, Taichi Sugimoto, Masaya Kobayashi, Mitsuyuki Shirai, Fumitoshi Asai

    Published 2018-01-01
    “…High-salt intake is a major risk factor for developing hypertension in type 2 diabetes mellitus, but its effects on glucose homeostasis are controversial. …”
    Get full text
    Article
  15. 835

    Non-HDL cholesterol: A valid surrogate marker to apolipoprotein b100 in type 2 diabetes mellitus patients in assessment of risk of cardiovascular diseases by Vidyashree, Lakshmi D, Prashanth D, Indushree T, Hamsaveena

    Published 2024-07-01
    “…Background: Considering the cardiovascular complications in Type 2 Diabetes Mellitus (T2DM) despite normal Total Cholesterol (TC) and Low Density Lipoprotein (LDL) levels, Non High Density Lipoprotein (non-HDL-C) and Apolipoprotein B (ApoB) were added as secondary targets and have been increasingly acknowledged as measures of risk estimation for developing atherosclerotic Cardiovascular Disease (CVD). …”
    Get full text
    Article
  16. 836

    Mean Daily Dosage of Aspirin and the Risk of Incident Alzheimer’s Dementia in Patients with Type 2 Diabetes Mellitus: A Nationwide Retrospective Cohort Study in Taiwan by Cheng-Wei Chang, Jorng-Tzong Horng, Chi-Chang Hsu, Jui-Ming Chen

    Published 2016-01-01
    “…Background. Type 2 diabetes mellitus patients are known to have higher risk of developing dementia while aspirin use has been shown to prevent incident dementia. …”
    Get full text
    Article
  17. 837

    GLP-1 Gene-Modified Human Umbilical Cord Mesenchymal Stem Cell Line Improves Blood Glucose Level in Type 2 Diabetic Mice by Ying Chang, Mingxin Dong, Yan Wang, Haotian Yu, Chengbiao Sun, Xin Jiang, Wei Chen, Xin Wang, Na Xu, Wensen Liu, Ningyi Jin

    Published 2019-01-01
    “…Type 2 diabetes constitutes a serious threat to the health of patients, but there is currently no ideal treatment in the clinic. …”
    Get full text
    Article
  18. 838
  19. 839

    Comparison of Two New Mouse Models of Polygenic Type 2 Diabetes at the Jackson Laboratory, NONcNZO10Lt/J and TALLYHO/JngJ by Edward H. Leiter, Marjorie Strobel, Adam O'Neill, David Schultz, Andrew Schile, Peter C. Reifsnyder

    Published 2013-01-01
    “…This review compares two novel polygenic mouse models of type 2 diabetes (T2D), TALLYHO/JngJ and NONcNZO10/LtJ, and contrasts both with the well-known C57BLKS/J-Leprdb (db/db) monogenic diabesity model. …”
    Get full text
    Article
  20. 840